AKT1 and cancer: Apart from mutations and aberrations in the major nodes of the PI3K/Akt pathway resulting in its dysregulation in favor of cancer growth and survival, other factors, including non-coding RNAs, cell adhesion molecules, and oncogenes (such as RAS), may also interact with this pathway in different tumors.